TickrTrends STAA fair value analysis

STAAR Surgical (STAA) Swings To Profit On China Rebound

insidermonkey.com · 2026-09-14

On August 12, STAAR Surgical (NASDAQ:STAA) reported results for the quarter ended July 3 that flipped the script from a year earlier.

TickrTrends take: STAAR Surgical's return to profitability amid China market recovery provides a concrete earnings development that supports TickrTrends' undervalued assessment for the Healthcare sector company. Valuation-focused readers should monitor whether this profitability swing translates into sustained margin expansion and whether China revenue growth maintains momentum, as these factors will be critical to justifying any price appreciation from current levels. The company's ability to convert geographic diversification into reliable earnings growth will determine if the undervalued designation proves prescient or requires recalibration.

Read the full story at insidermonkey.com →

Is STAA undervalued? See TickrTrends' fair value analysis →